Overview of CT and MRI Techniques of the Liver

  • Tara SagebielEmail author
  • Janio Szkarluk


This chapter provides an illustrative practical overview of the utility of most CT and MRI techniques used for the clinical evaluation of the liver.


Liver Computed tomography Magnetic resonance imaging 


  1. 1.
    Dwyer A, et al. Influence of glycogen on liver density: computed tomography from a metabolic perspective. J Comput Assist Tomogr. 1983;7(1):70–3.CrossRefGoogle Scholar
  2. 2.
    Kamel IR, Liapi E, Fishman EK. Multidetector CT of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):63–89.CrossRefGoogle Scholar
  3. 3.
    Monzawa S, et al. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol. 2007;188(1):147–53.CrossRefGoogle Scholar
  4. 4.
    Yeh BM, et al. Dual-energy and low-kVp CT in the abdomen. AJR Am J Roentgenol. 2009;193(1):47–54.CrossRefGoogle Scholar
  5. 5.
    Mulkens TH. Dose management in Multidetector Computed Tomography (MDCT): modalities for dose reduction and clinical studies. Belgium: Universiteit Antwerpen; 2008. 223.Google Scholar
  6. 6.
    Boll DT, Merkle EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics. 2009;29(6):1591–614.CrossRefGoogle Scholar
  7. 7.
    Goshima S, et al. MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases. AJR Am J Roentgenol. 2006;187(1):W25–32.CrossRefGoogle Scholar
  8. 8.
    Yu JS, et al. Hepatic MRI using the double-echo chemical shift phase-selective gradient-echo technique. AJR Am J Roentgenol. 2007;188(1):W49–56.CrossRefGoogle Scholar
  9. 9.
    Deshmane A, et al. Parallel MR imaging. J Magn Reson Imaging. 2012;36(1):55–72.CrossRefGoogle Scholar
  10. 10.
    Alustiza JM, Castiella A. Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology. 2008;246(2):641.CrossRefGoogle Scholar
  11. 11.
    Westbrook C, Roth CK, Talbot J. MRI in practice. 3rd ed. Malden: Blackwell; 2005. xii, 410 p.Google Scholar
  12. 12.
    Low RN. Abdominal MRI, advances in the detection of liver tumours and characterisation. Lancet Oncol. 2007;8(6):525–35.CrossRefGoogle Scholar
  13. 13.
    Li T, Mirowitz SA. Fast T2-weighted MR imaging: impact of variation in pulse sequence parameters on image quality and artifacts. Magn Reson Imaging. 2003;21(7):745–53.CrossRefGoogle Scholar
  14. 14.
    Huang J, et al. Utility of breath-hold fast-recovery fast spin-echo t2 versus respiratory-triggered fast spin-echo T2 in clinical hepatic imaging. AJR Am J Roentgenol. 2005;184(3):842–6.CrossRefGoogle Scholar
  15. 15.
    Semelka RC. Abdominal-pelvic MRI. Hoboken: Wiley; 2006.Google Scholar
  16. 16.
    Leyendecker JR, Brown JJ, Merkle EM. Practical guide to abdominal & pelvic MRI. 2nd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011. ix, 406 p.Google Scholar
  17. 17.
    Morrin MM, Rofsky NM. Techniques for liver MR imaging. Magn Reson Imaging Clin N Am. 2001;9(4):675–96. v.PubMedGoogle Scholar
  18. 18.
    Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254(1):47–66.CrossRefGoogle Scholar
  19. 19.
    Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging. 2007;25(4):848–58.CrossRefGoogle Scholar
  20. 20.
    Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am. 2010;18(3):451–64. x.CrossRefGoogle Scholar
  21. 21.
    Bhosale P, Ma J, Choi H. Utility of the FIESTA pulse sequence in body oncologic imaging: review. AJR Am J Roentgenol. 2009;192(6 Suppl):S83–93. Quiz S94–7.CrossRefGoogle Scholar
  22. 22.
    Motosugi U, et al. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009;19(11):2623–9.CrossRefGoogle Scholar
  23. 23.
    Tsao J, Kozerke S. MRI temporal acceleration techniques. J Magn Reson Imaging. 2012;36(3):543–60.CrossRefGoogle Scholar
  24. 24.
    Yoon SH, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol. 2009;193(6):W482–9.CrossRefGoogle Scholar
  25. 25.
    Sadowski EA, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243(1):148–57.CrossRefGoogle Scholar
  26. 26.
    Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14(4):559–78.CrossRefGoogle Scholar
  27. 27.
    Karabulut N, Cakmak V, Kiter G. Confident diagnosis of bronchobiliary fistula using contrast-enhanced magnetic resonance cholangiography. Korean J Radiol. 2010;11(4):493–6.CrossRefGoogle Scholar
  28. 28.
    Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol. 2012;57(2):421–9.CrossRefGoogle Scholar
  29. 29.
    Husarik DB, et al. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol. 2011;18(12):1549–54.CrossRefGoogle Scholar
  30. 30.
    Gschwend S, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46(9):556–66.CrossRefGoogle Scholar
  31. 31.
    Tamada T, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging. 2009;29(3):636–40.CrossRefGoogle Scholar
  32. 32.
    Tamada T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80(3):e311–6.CrossRefGoogle Scholar
  33. 33.
    Petersein J, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging–a multicenter phase III clinical study. Radiology. 2000;215(3):727–36.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations